Aims: The aims of the current study were to determine the prevalence of epidermal growth
factor (EGFR) receptor in patients diagnosed with esophageal squamous cell carcinoma …

Background The overall survival of patients with esophageal squamous cell carcinoma
(ESCC) remains poor. Prognostic predictions in ESCC are usually based on histological …

Background: The epidermal growth factor receptor (EGFR) has become a promising target
for novel anticancer therapy. Evaluation of its biological profiles including gene mutation …

Alterations of the epidermal growth factor receptor (EGFR), including overexpression or
gene mutations, contribute to the malignant transformation of human epithelial cells. The aim …

The aim of the current study was to investigate the prognostic significance of epidermal
growth factor receptor (EGFR) in patients with locally advanced esophageal squamous cell …

Background: Esophageal squamous cell carcinoma (ESCC) is the predominant type of
esophageal cancer in the Asian belt. These cancers show poor prognosis with an overall 5 …

BACKGROUND. The prognosis for patients with esophageal and esophagogastric junction
(EGJ) adenocarcinoma remains poor, even after surgical resection. Pathologic assessment …

Background. Many studies have reported the increased expression of epidermal growth
factor receptor (EGFR) in various human malignancies and its association with the biologic …

Overexpression of epidermal growth factor receptor (EGFR) is observed in many cancers,
sometimes accompanied by gene amplification. Recently, several clinical therapies …

Esophageal squamous cell carcinoma (ESCC) exhibits abnormalities in epidermal growth
factor receptor (EGFR) gene. To identify a prognostic marker, the overexpression of EGFR …